Capital World Investors Agios Pharmaceuticals, Inc. Transaction History

Capital World Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $4.04 Million - $5.95 Million	-88,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $23.8 Million - $30.5 Million	-332,000 Reduced 79.05%	88,000 $6.79 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $14.5 Million - $21 Million	-243,000 Reduced 36.65%	420,000 $34.3 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $36.4 Million - $44.5 Million	663,000	663,000 $44.3 Million

244

59.9M

270K

332K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.72B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.